Pharmaceutical regulation governs the discovery, development, manufacturing, marketing, and post-market surveillance of small-molecule drugs and biological products. The FDA’s Center for Drug Evaluation and Research (CDER) regulates most drugs; the Center for Biologics Evaluation and Research (CBER) regulates therapeutic biologics, vaccines, and certain advanced therapies. Submissions move through pathways with distinct vocabularies: IND for clinical investigation, NDA for new drugs, BLA for biologics, ANDA for generics, 505(b)(2) for hybrid pathways. The manufacturing side is governed by cGMP under 21 CFR Parts 210 and 211, harmonized with ICH Q8 (Quality by Design), Q9 (Quality Risk Management), and Q10 (Pharmaceutical Quality System). Clinical investigations follow ICH GCP E6(R3); pharmacovigilance is structured by 21 CFR Part 314.80 and ICH E2 documents.

This 16-hour Professional Certificate Course is the entry point of the Aleph Pharmaceutical Product Regulation course track. It introduces the FDA pharmaceutical framework, the submission pathway vocabulary, cGMP under 21 CFR Parts 210 and 211 at orientation depth, the ICH Q8 / Q9 / Q10 trio, ICH GCP E6(R3) at orientation depth, and pharmacovigilance at orientation depth.

The course prepares participants for the Advanced level (`RAQ-640-A`), where the same content is exercised at applied depth — applied IND content planning, applied NDA / BLA module mapping, applied cGMP gap analysis, applied ICH Q8 QbD documentation, applied ICH Q9 risk-management decisions, applied ICH Q10 Pharmaceutical Quality System artifacts, applied GCP-aligned trial-document review, and a capstone integrated pharmaceutical regulatory plan. Together the Introductory and Advanced levels form a 48-hour course track.

The Introductory course establishes the pharmaceutical regulatory vocabulary the industry expects of someone entering Regulatory Affairs, Quality, Clinical Operations, or Pharmacovigilance roles. Employers in this space include pharmaceutical manufacturers, biologic manufacturers, generics manufacturers, contract research organizations (CROs), contract manufacturing organizations (CMOs/CDMOs), and consultancies serving the pharmaceutical industry.

Participants who meet the course completion requirements receive a Certificate of Completion issued by Aleph University.